Cardiovascular Revascularization Medicine
Volume 6, Issue 4 , Pages 140-146 , October 2005

Comparison of a centered 32P source wire system with a noncentered 90Sr/Y brachytherapy system for intracoronary β-radiation following PCI of diffuse in-stent restenosis

  • Jürgen Haase

      Affiliations

    • Red Cross Hospital Cardiology Center, Frankfurt/Main, Germany
    • Corresponding Author InformationCorresponding author. Tel.: +49 69 94434 153; fax: +49 69 483276.
    • ,
  • Peter von Neumann-Cosel

      Affiliations

    • Institute of Nuclear Physics, University of Technology, Darmstadt, Germany
    • ,
  • Michael Damm

      Affiliations

    • Red Cross Hospital Cardiology Center, Frankfurt/Main, Germany
    • ,
  • Manfred Hofmann

      Affiliations

    • Red Cross Hospital Cardiology Center, Frankfurt/Main, Germany
    • ,
  • Hans Störger

      Affiliations

    • Red Cross Hospital Cardiology Center, Frankfurt/Main, Germany
    • ,
  • Daniel Isner

      Affiliations

    • Red Cross Hospital Cardiology Center, Frankfurt/Main, Germany
    • ,
  • Michael Bergmann

      Affiliations

    • Red Cross Hospital Cardiology Center, Frankfurt/Main, Germany
    • ,
  • Claudia Piancatelli

      Affiliations

    • Red Cross Hospital Cardiology Center, Frankfurt/Main, Germany
    • ,
  • Volker Schächinger

      Affiliations

    • Department of Cardiology, University Hospital, Frankfurt/Main, Germany
    • ,
  • Franz Schwarz

      Affiliations

    • Red Cross Hospital Cardiology Center, Frankfurt/Main, Germany

Received 29 September 2005 ,Accepted 29 September 2005.

References 

  1. Morice MC, Serruys PW, Sousa JE, Fajadet J, Ban Hayashi E, Perin M, et al. A randomized comparison of a sirolimus-eluting stent with a standard stent for coronary revascularization. N Engl J Med. 2002;346:1773–1780
  2. Moses JW, Leon MB, Popma JJ, Fitzgerald PJ, Holmes DR, O'Shaughnessy C, et al. Sirolimus-eluting stents versus standard stents for treatment of patients with stenosis in a native coronary artery. N Engl J Med. 2003;349:1315–1323
  3. Stone GW, Ellis SG, Cox DA, Hermiller J, O'Shaughnessy C, Mann JT, et al. A polymer-based, paclitaxel-eluting stent in patients with coronary disease. N Engl J Med. 2004;350:221–223
  4. Castrati A, Mehilli J, von Beckerath N, Dibra A, Hausleiter J, Pache J, et al. Sirolimus-eluting stent or paclitaxel-eluting stent vs balloon angioplasty for prevention of recurrences in patients with coronary in-stent restenosis. JAMA. 2005;293:165–171
  5. Neumann FJ, Desmet W, Grube E, Brachmann J, Presbitero P, Rubartelli P, et al. Effectiveness and safety of sirolimus-eluting stents in the treatment of restenosis after coronary stent placement. Circulation. 2005;111:2107–2111
  6. Teirstein PS, Massullo V, Jani S, Popma JJ, Mintz GS, Russo RJ, et al. Catheter-based radiotherapy to inhibit restenosis after coronary stenting. N Engl J Med. 1997;336:1697–1703
  7. Leon MB, Teirstein PS, Moses JW, Tripuraneni P, Lansky AJ, Jani S, et al. Localized intracoronary gamma radiation therapy to inhibit the recurrence of restenosis after stenting. N Engl J Med. 2001;344:250–256
  8. Waksman R, Raizner AE, Yeung AC, Lansky AJ, Vandertie L. Use of localised intracoronary beta-radiation in treatment of in-stent restenosis: the INHIBIT randomised controlled trial. Lancet. 2002;359:551–557
  9. Waksman R, Ajani AE, White RL, Chan RC, Satler LF, Kent KM, et al. Intravascular gamma radiation for in-stent restenosis in saphenous vein bypass grafts. N Engl J Med. 2002;346:1194–1199
  10. Popma JJ, Suntharalingam M, Lansky AJ, Heuser RR, Speiser B, Teirstein PS, et al. Randomized trial of 90Sr/90Y β-radiation versus placebo control for treatment of in-stent restenosis. Circulation. 2002;106:1090–1096
  11. Grise MA, Massulo V, Jani S, Popma JJ, Russo RJ, Schatz RA, et al. Five-year clinical follow-up after intracoronary radiation—results of a randomized clinical trial. Circulation. 2002;105:2737–2740
  12. Soares CG, Halpern DG, Wang CK. Calibration and characterization of beta-particle sources for intravascular brachytherapy. Med Phys. 1998;25:339–346
  13. Jani SK. Basic physics of gamma isotopes. In:  Waksman R editors. Vascular brachytherapy. New York: Futura Publishing Company; 1999;p. 167–176
  14. Raizner AE, Calfee RV, Ali MN, Bradshaw AJ, Eno RP. The Guidant coronary source wire system. In:  Waksman R editors. Vascular brachytherapy. New York: Futura Publishing Company; 1999;p. 505–519
  15. King SB, Williams DO, Chougule P, Klein JL, Waksman R, Hilstead R, et al. Endovascular beta-radiation to reduce restenosis after coronary balloon angioplasty; results of the beta energy restenosis trial (BERT). Circulation. 1998;97:2025–2030
  16. Scott NA, Cipolla GD, Ross CE, Dunn B, Martin FH, Simonet L, et al. Identification of a potential role for the adventitia in vascular lesion formation after balloon overstretch injury of porcine coronary arteries. Circulation. 1996;93:2178–2187
  17. Scott RJ, Hall PA, Haldane JS. A comparison of immunohistochemical markers of cell proliferation with experimentally determined growth fraction. J Pathol. 1991;165:173–178
  18. Popowski Y, Verin V. Debate: centering is important. J Interv Cardiol. 1999;12:243–245
  19. Crocker I, Robinson K, Bonan R. Active centering is not important in intracoronary radiation therapy. J Interv Cardiol. 1999;12:247–253
  20. Amols HI, Zaider M, Weinberger J, Ennis R, Schiff PB, Reinstein LE. Dosimetric considerations for catheter-based beta and gamma emitters in the therapy of neointimal hyperplasia in human coronary arteries. Int J Radiat Oncol Biol Phys. 1996;36:913–921
  21. Sehgal V, Li Z, Palta J, Bolch WE. Dosimetric effect of source centering and residual plaque for beta-emitting catheter-based intravascular brachytherapy sources. Med Phys. 2001;28:2162–2171
  22. Rahdert DA, Sweet LS, Tio FO, Janicki C, Duggan DM. Measurement of density and calcium in human atherosclerotic plaque and implantations for arterial brachytherapy. Cardiovasc Radiat Med. 1999;1:358–367
  23. Ahmed JM, Mintz GS, Waksman R, Weissman NJ, Leiboff B, Pichard AD, et al. Serial intravascular ultrasound analysis of the impact of lesion length on the efficacy of intracoronary gamma-radiation for preventing recurrent in-stent restenosis. Circulation. 2001;103:188–191
  24. Mintz GS, Weissmann NJ, Fitzgerald PJ. Intravascular ultrasound assessment of the mechanisms and results of brachytherapy. Circulation. 2001;104:1320–1352
  25. Arab-Zadeh A, Russo RJ, Bhargava V, Jani SK, Kimura BJ, Massullo V, et al. Centering of the radiation source in the artery lumen results in crucial improvement of radiation dose heterogeneity in saphenous vein grafts: observations from the SCRIPPS trial. Circulation. 1998;98(Suppl I):I–779
  26. Bhargava B, Mintz GS, Leiboff BO. Cross-sectional measurements after treatment of in-stent restenosis: an intravascular ultrasound guide for intracoronary radiation dosimetry. J Am Coll Cardiol. 1999;33:53 A
  27. Ajani AE, Waksman R, Cha DH, Gruberg L, Satler LF, Pichard AD, et al. The impact of lesion length and reference diameter on angiographic restenosis and target vessel revascularization in treating in-stent restenosis with radiation. J Am Coll Cardiol. 2002;39:1290–1296

PII: S1553-8389(05)00133-8

doi: 10.1016/j.carrev.2005.09.002

Cardiovascular Revascularization Medicine
Volume 6, Issue 4 , Pages 140-146 , October 2005

Article Tools

* Image Usage & Resolution